Antibiotic consumption and medication cost in diabetic patients: Insights from Iran health insurance organization (IHIO) claims data.

ABSTRACT:

Background

The rising prevalence of diabetes is increasing the healthcare costs especially when associated with infection. We aimed to assess the antibiotic consumption and medication costs in diabetes.

Methods

We performed a retrospective claims-based study using Iranian Health Insurance Organization (IHIO) dataset from 24 provinces during 2014-2017. Systemic antibacterials were quantified in defined daily doses and diabetic patients were stratified into "No antibiotic" (NAb) and quartiles of cumulative antibiotic exposure (Q1-Q4). A dominant antidiabetic regimen was assigned when ≥80% of a patient's diabetes prescriptions came from one drug class or combination. Inflation-adjusted annual medication costs were modelled with log-link Gamma generalized linear models.

Resul

SUBMITTER: Ghotbi AB 

PROVIDER: S-EPMC12948126 | biostudies-literature | 2026

REPOSITORIES: biostudies-literature